Bio-Techne (TECH) Asset Writedowns and Impairment (2012 - 2025)

Bio-Techne's Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at $84.2 million for Q2 2025.

• On a quarterly basis, Asset Writedowns and Impairment rose 428.46% year-over-year to $84.2 million in Q2 2025; TTM through Jun 2025 was $96.4 million, a 505.51% increase from a year earlier, with the FY2025 full-year figure at $80.5 million, up 266.54% from the prior year.
• Asset Writedowns and Impairment climbed to $84.2 million in Q2 2025 per TECH's latest filing, from -$3.7 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $84.2 million in Q2 2025 and bottomed at -$3.7 million in Q1 2025.
• The 3-year median for Asset Writedowns and Impairment is $15.9 million (2024), against an average of $23.1 million.
• Biggest YoY gain for Asset Writedowns and Impairment was 428.46% in 2025; the steepest drop was 428.46% in 2025.
• Year by year, Asset Writedowns and Impairment stood at $18.7 million in 2021, then decreased by 14.91% to $15.9 million in 2024, then soared by 428.46% to $84.2 million in 2025.
• Per Business Quant, the three latest TECH Asset Writedowns and Impairment figures stand at $84.2 million (Q2 2025), -$3.7 million (Q1 2025), and $15.9 million (Q2 2024).